Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: Preliminary Results of an IFM Phase II Study
暂无分享,去创建一个
J. Harousseau | V. Coiteux | M. Attal | A. Stoppa | C. Hulin | L. Benboubker | M. Renaud | J. Fuzibet | A. M. Stoppa